Acquired Disorders of Platelet Function

152 วีระศักดิ์ นาวารวงศPreoperative antiplatelet therapy does not increasetheriskofspinalhematomaassociatedwithregionalanesthesia. Anesth Analg 1995;80:303-9.212. Simon SL, Mills JA. Non-steroidal anti-inflammatorydrugs. N Engl J Med 1980;302:1119.213. McQueen EG, Facoory B, Faed JM. Non-steroidalanti-inflammatory drugs and platelet function. N ZMed J 1986;99:358-60.214. Buchanan GR, Martin V, Levine PH, Scoon K,Handin RI. The effects of “anti-platelet” drugs onbleeding time and platelet aggregation in normalhuman subjects. Am J Clin Pathol 1977;68:355-9.215. Kenny GN. Potential renal, haematological and allergicadverse effects associated with nonsteroidal antiinflammatorydrugs. Drugs 1992;44(Suppl 5):31-7.216. Thomas P, Hepburn B, Kim HC, Saidi P. Nonsteroidal anti-inflammatory drugs in the treatment ofhemophilic arthropathy. Am J Hematol 1982;12:131-7.217. Ragni MV, Miller BJ, Whalen R, Ptachcinski R.Bleeding tendency, platelet function, and pharmacohinetics of ibuprofen and zidovudine in HIV(+)hemophilic men. Am J Hematol 1992;40:176.218. Garcia podriguez LA, Cattaruzzi C, Troncon MG,Agostinis L. Risk of hospitalization for uppergastrointestinal tract bleeding associated withketorolac, other nonsteroidal anti-inflammatory drugs,calcium antagonists, and other antihypertensivedrugs. Arch Intern Med 1998;158:33.219. McTavish D, Faulds D, Goa KL. Ticlopidine: Anupdated review of its pharmacology and therapeuticuse in platelet-dependent disorders. Drugs 1992;40:238.220. CAPRIE Steering Committee:A randomized, blinded,trial of clopidogrel versus aspirin in patients at riskof ischaemic events (CAPRIE). Lancet 1996;48:1329.221. Rupprecht HJ, Darius H, Borkowski U, et al.Comparison of antiplatelet effects of aspirin,ticlopidine, or their combination after stentimplantation. Circulation 1998;97:1046.222. Leon MB, Baim DS, Popma JJ, et al. A clinical trialcomparing three antithrombotic-drug regimens aftercoronary-artery stenting: Stent Anti-coagulationRestenosis Study investigators [comments]. N EnglJ Med 1998;339:1665.223. Sharis PJ, Cannon CP, Loscalzo J. The antiplateleteffects of ticlopidine and clopidogrel. Ann InternMed 1998;129:394.224. Bossavy JP, Thalamas C, Sagnard L, et al. A doubleblindrandomized comparison of combined aspirinand ticlopidine therapy versus aspirin or ticlopidinealone on experimental arterial thrombogenesis inhumans. Blood 1998;92:1518.225. Patrono C, Coller B, Dalen JE, et al. Platelet-activedrugs: the relationships among among dose,effectiveness, and side effects. Chest 1998;114:470S.226. Coller BS. Platelet GPIIb/IIIa antagonists: the firstanti-integrin receptor therapeutics. J Clin Invest1997;100:S57.227. Topol EJ, Byzova TV, Plow EF. Platelet GPIIb-IIIablockers. Lancet 1999;353:227.228. Coller BS. Anti-GPIIb/IIIa drugs: Current strategiesand future directions. Thromb Haemost 2001;86:427-43.229. Kohl DW, Slavik KJ, Kamath G, et al High-doseabciximab during coronary angioplasty in a patientwith essential thrombocytosis. J Inva Cardiol1998;10:173-6.230. Scarborough RM, Rose JW, Hsu MA, et alBarbourin: A GPIIb-IIIa-specific integrin antagonistfrom the venom of Sistrurus m. barbouri. J BiolChem 1991;266:9359-62.231. Sattler FR, Weitekamp MR, Ballard JO. Potential forbleedingwiththenewbeta-lactam antibiotics. AnnIntern Med 1986;105:924.232. Brown CH III, Natelson EA, Bradshaw MW, WilliamsTW Jr, Alfrey CP Jr. The hemostatic defect producedby carbenicillin. N Engl J Med 1974;291:265.233. Haburchak DR, Head DR, Everett ED. Postoperativehemorrhage associated with carbenicillin administration-reportof two cases and review of theliterature. Am J Surg 1977;134:630.234. Brown CH III, Bradshaw MW, Natelson EA, Alfrey CPJr, Williams TW Jr. Defective platelet functionThai Journal of Hematology and Transfusion Medicine Vol. 16 No. 2 April-June 2006